You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 1, July 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tranylcypromine Sulfate Poisoning

Successful Treatment by Hemodialysis

BILLY J. MATTER, MD; PAUL E. DONAT, MD; MELVYN L. BRILL, MD; H. EARL GINN, JR., MD

Arch Intern Med. 1965;116(1):18-20.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE INITIAL investigations of monoamine oxidase (MAO) inhibitors, commonly used to treat depression reactions, were favorable,1,2 although adverse reactions such as dryness of mouth, postural hypotension, dizziness, and central nervous system disturbances occurred.2,3 There have been several recent reports of severe hypertensive crises in patients taking drugs of this group.4-13 A total of 22 fatalities from overdosage has been recorded.14-21 Therapy for the overdosage of MAO inhibitors has consisted of withdrawal of the drug and symptomatic measures. The use of hemodialysis for removal of tranylcypromine (Parnate) sulfate, a potent MAO inhibitor, has not been previously reported.15

Report of Case

A 15-year-old white girl ingested 350 mg of tranylcypromine sulfate during an episode of psychic depression. Within six hours she became irrational and developed generalized muscular hyperactivity. Twenty-three hours after ingestion of the tablets, she was admitted to the Oklahoma University Hospital, Oklahoma City. Her blood pressure was 100/60 mm Hg; . . . [Full Text PDF of this Article]


Author Affiliations

OKLAHOMA CITY

From the Department of Medicine, University of Oklahoma Medical Center and Medical Service, Veterans Administration Hospital, Oklahoma City. The University of Oklahoma School of Medicine: Fellow in the Department of Medicine (Drs. Matter and Donat); Resident in the Department of Medicine (Dr. Brill); and Assistant Professor of Medicine and Physiology and recipient of the US Public Health Service Career Research Development Award (Dr. Ginn).


Footnotes

Received for publication Oct 10, 1964; accepted Jan 15, 1965.

Reprint requests to Veterans Administration Hospital, Nashville, Tenn 37203 (Dr. Ginn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.